Class IIOngoingD-1507-2020
Drug recall · August 26, 2020
Elitek (rasburicase) for injection recall
Why: Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75
- Lots / codes
Lot #: A9306, Exp 2/28/2022
- Quantity
- 7451 vials
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Nationwide in the US
- Initiated
- August 10, 2020 · Voluntary: Firm initiated
- Classified
- August 17, 2020
- Reported
- August 26, 2020
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.